Biologically-Active Medical Devices Manufactured from Blood Plasma

Carmell Therapeutics is developing biologically-active medical devices, with growth and regenerative factors designed by nature in the right proportions to heal tissues.

News

5/19/14   Carmell Therapeutics Receives NIH Phase I Grant to develop antimicrobial-eluting bioresorbable bone filler.   May 19, 2014 – PITTSBURGH -- Carmell Therapeutics, a company that is developing novel products manufactured from blood plasma, which naturally accel[...]
4/1/14   Carmell Innovation Showcase Winner at ACA 2014 Summit   With the largest gathering of angel investors from around the world present, the Angel Capital Association's (ACA) 2014 Summit featured presentations [...]
9/26/13   September 10, 2013: Five new U.S. Patents issued   Five new U.S. Patents have issued bringing to a total of 6 issued patents with additional U.S. and foreign applications. These five patents (8,529,95[...]
4/19/13   Can New Plasma-Based Biomaterials Speed Healing of Injured Tissues?   New Rochelle, NY, April 15, 2013—Platelet-rich plasma (PRP) derived from blood contains growth factors and other bioactive molecules that promote he[...]